广州伟伯科技有限公司
您的位置:首页 > 产品中心 > Anti-NK3R antibody produced in rabbit
产品搜索:

Anti-NK3R antibody produced in rabbit

产品编号:4111099
规格:affinity isolated antibody, buffered aqueous solution
包装规格:100 渭G
产品类别:进口试剂
品牌:Sigma-Aldrich
优惠价:立即咨询
产品价格
产品编号包装单位单价(元)国内现货国外库存询价单
4111099100 渭G5000
产品别名

Anti-NK3R antibody produced in rabbit

Anti-TACR3

Anti-Tachykinin receptor 3

Anti-NK-3R

Anti-NK-3 receptor

Anti-Neurokinin B receptor

鍩烘湰淇℃伅
MDL number
MFCD01633907
NACRES
NA.41
Immunogen【鍏嶇柅鍘煛
NK3R antibody was raised against a 18 amino acid peptide from near the center of human NK3R.
Features and Benefits【鐗圭偣鍜屼紭鍔俊
Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.
Linkage【鑱旂郴】
The action of this antibody can be blocked using blocking peptide SBP3500368.
Physical form【澶栧舰】
Supplied in PBS with 0.02% sodium azide.
浜у搧鎬ц川
biological source【鐢熺墿鏉ユ簮】
rabbit
Quality Level【璐ㄩ噺姘村钩】
100
conjugate【鍋惰仈鐗
unconjugated
antibody form【鎶椾綋褰㈠紡】
affinity isolated antibody
antibody product type
primary antibodies
clone【鍏嬮殕】
polyclonal
form【褰㈠紡】
buffered aqueous solution
mol wt【鍒嗗瓙閲彙
predicted mol wt 51 kDa
species reactivity
human, mouse
technique(s)
immunofluorescence: suitable
immunohistochemistry: suitable
indirect ELISA: suitable
western blot: suitable
NCBI accession no.【NCBI鐧昏鍙贰
P29371
UniProt accession no.【UniProt鐧昏鍙贰
P29371
shipped in【杩愯緭】
dry ice
storage temp.【鍌ㄥ瓨娓╁害】
−20鈩
Gene Information
human ... TACR3(6870)
浜у搧璇存槑
Disclaimer【鍏嶈矗澹版槑】
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
瀹夊叏淇℃伅
Storage Class Code【鍌ㄥ瓨鍒嗙被浠g爜】
12 - Non Combustible Liquids
WGK
WGK 2
广州伟伯科技有限公司 版权所有 CopyRight ©2006-2026, All Rights Reserved
Page Run Time: 0.0159